XW133E7Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- Billable / Specific Code
XW133E7 is a billable ICD-10-PCS procedure code for Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Transfusion involves putting in blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | W | Anatomical Regions |
| 3 | Operation | 1 | Transfusion |
| 4 | BodyPart | 3 | Peripheral Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | E | Hyperimmune Globulin |
| 7 | Qualifier | 7 | New Technology Group 7 |
Code History
- 30233S1 — Transfuse of Nonaut Globulin into Periph Vein, Perc Approach
Similar Procedure Codes
Questions About XW133E7
Is XW133E7 a billable code?
Yes. XW133E7 is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XW133E7 mean?
XW133E7 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character E is the Device/Substance/Technology (Hyperimmune Globulin); the 7th character 7 is the Qualifier (New Technology Group 7).
